Patents by Inventor Francis Thompson

Francis Thompson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210193600
    Abstract: In some examples, a package comprises a die and a redistribution layer coupled to the die. The redistribution layer comprises a metal layer, a brass layer abutting the metal layer, and a polymer layer abutting the brass layer.
    Type: Application
    Filed: December 19, 2019
    Publication date: June 24, 2021
    Inventors: Vivek Swaminathan SRIDHARAN, Christopher Daniel MANACK, Nazila DADVAND, Salvatore Frank PAVONE, Patrick Francis THOMPSON
  • Publication number: 20210066229
    Abstract: A semiconductor die includes a substrate and an integrated circuit provided on the substrate and having contacts. An electrically conductive layer is provided on the integrated circuit and defines electrically conductive elements electrically connected to the contacts. Electrically conductive interconnects coupled with respective electrically conductive elements. The electrically conductive interconnects have at least one of different sizes or shapes from one another.
    Type: Application
    Filed: November 10, 2020
    Publication date: March 4, 2021
    Inventors: PATRICK FRANCIS THOMPSON, CHRISTOPHER DANIEL MANACK, STEFAN HERZER, RAKSHIT AGRAWAL
  • Patent number: 10833036
    Abstract: A semiconductor die includes a substrate and an integrated circuit provided on the substrate and having contacts. An electrically conductive layer is provided on the integrated circuit and defines electrically conductive elements electrically connected to the contacts. Electrically conductive interconnects coupled with respective electrically conductive elements. The electrically conductive interconnects have at least one of different sizes or shapes from one another.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: November 10, 2020
    Assignee: TEXAS INSTRUMENTS INCORPORATED
    Inventors: Patrick Francis Thompson, Christopher Daniel Manack, Stefan Herzer, Rakshit Agrawal
  • Publication number: 20200211992
    Abstract: A semiconductor die includes a substrate and an integrated circuit provided on the substrate and having contacts. An electrically conductive layer is provided on the integrated circuit and defines electrically conductive elements electrically connected to the contacts. Electrically conductive interconnects coupled with respective electrically conductive elements. The electrically conductive interconnects have at least one of different sizes or shapes from one another.
    Type: Application
    Filed: December 27, 2018
    Publication date: July 2, 2020
    Inventors: PATRICK FRANCIS THOMPSON, CHRISTOPHER DANIEL MANACK, STEFAN HERZER, RAKSHIT AGRAWAL
  • Patent number: 9682978
    Abstract: The present invention provides 2,6,7 substituted purines as described herein or a pharmaceutically acceptable salt thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.
    Type: Grant
    Filed: February 4, 2014
    Date of Patent: June 20, 2017
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Matthew P. Christopher, Francesc Xavier Fradera Llinas, Michelle Machacek, Michelle Martinez, Michael Hale Reutershan, Manami Shizuka, Binyuan Sun, Christopher Francis Thompson, B. Wesley Trotter, Matthew E. Voss, Liping Yang
  • Patent number: 9637493
    Abstract: The present invention provides substituted pyrrolopyrimidines of Formula I as described herein or a pharmaceutically acceptable salt or solvate thereof: The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: May 2, 2017
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Christopher Dinsmore, Francesc Xavier Fradera Llinas, Amit Ashokro Kudale, Michelle Machacek, Michael Hale Reutershan, Christopher Francis Thompson, B. Wesley Trotter, Liping Yang, Michael D. Altman, Stephane L. Bogen, Ronald J. Doll, Matthew E. Voss
  • Patent number: 9540377
    Abstract: The present invention provides 2,6,7,8 Substituted Purines as described herein or a pharmaceutically acceptable salt thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: January 10, 2017
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Carolyn Michele Cammarano, Matthew P. Christopher, Christopher Dinsmore, Ronald J. Doll, Francesc Xavier Fradera Llinas, Chaomin Li, Michelle Machacek, Michelle Martinez, Latha G. Nair, Weidong Pan, Michael Hale Reutershan, Manami Shizuka, Dietrich P. Steinhuebel, Binyuan Sun, Christopher Francis Thompson, B. Wesley Trotter, Yaolin Wang, Liping Yang, Stephane L. Bogen, Matthew E. Voss, Jagannath Panda, Anthappan Tony Kurissery
  • Publication number: 20160379953
    Abstract: Circuitry is disclosed that includes a first conductive portion of a first die and a first conductive pillar electrically and physically connected to the first conductive portion. The first conductive pillar includes a first conductive pillar surface. A first bond connects the first conductive pillar surface to a first end of a bond wire.
    Type: Application
    Filed: June 24, 2015
    Publication date: December 29, 2016
    Inventors: Patrick Francis Thompson, Jeffrey Alan West, Thomas D. Bonifield, Fu-Kang Hsu, Ching-Lun Hsia
  • Publication number: 20150368247
    Abstract: The present invention provides 2,6,7 substituted purines as described herein or a pharmaceutically acceptable salt thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.
    Type: Application
    Filed: February 4, 2014
    Publication date: December 24, 2015
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Matthew P. Christopher, Francesc Xavier Fradera Llinas, Michelle Machacek, Michelle Martinez, Michael Hale Reutershan, Manami Shizuka, Binyuan Sun, Christopher Francis Thompson, B. Wesley Trotter, Matthew E. Voss, Liping Yang
  • Publication number: 20150353553
    Abstract: The present invention provides 2,6,7,8 Substituted Purines as described herein or a pharmaceutically acceptable salt thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.
    Type: Application
    Filed: January 29, 2014
    Publication date: December 10, 2015
    Applicant: MERCK SHARP & DOHME CORP.
    Inventors: Carolyn Michele Cammarano, Matthew P. Christopher, Christopher Dinsmore, Ronald J. Doll, Francesc Xavier Fradera Llinas, Chaomin Li, Michelle Machacek, Michelle Martinez, Latha G. Nair, Weidong Pan, Michael Hale Reutershan, Manami Shizuka, Dietrich P. Steinhuebel, Binyuan Sun, Christopher Francis Thompson, B. Wesley Trotter, Yaolin Wang, Liping Yang, Stephane L. Bogen, Matthew E. Voss, Jagannath Panda, Anthappan Tony Kurissery
  • Patent number: 8962611
    Abstract: The present invention provides substituted imidazopyridines as described herein or a pharmaceutically acceptable salt or solvate thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.
    Type: Grant
    Filed: August 21, 2014
    Date of Patent: February 24, 2015
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Matthew P. Christopher, Francesc Xavier Fradera Llinas, Michelle Machacek, Michelle Martinez, Michael Hale Reutershan, Manami Shizuka, Binyuan Sun, Christopher Francis Thompson, B. Wesley Trotter, Matthew E. Voss, Michael D. Altman, Stephane L. Bogen, Ronald J. Doll
  • Publication number: 20140357618
    Abstract: The present invention provides substituted imidazopyridines as described herein or a pharmaceutically acceptable salt or solvate thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.
    Type: Application
    Filed: August 21, 2014
    Publication date: December 4, 2014
    Inventors: Matthew P. Christopher, Francesc Xavier Fradera Llinas, Michelle Machacek, Michelle Martinez, Michael Hale Reutershan, Manami Shizuka, Binyuan Sun, Christopher Francis Thompson, B. Wesley Trotter, Matthew E. Voss, Michael D. Altman, Stephane L. Bogen, Ronald J. Doll
  • Patent number: 8846657
    Abstract: The present invention provides substituted imidazopyridines as described herein or a pharmaceutically acceptable salt or solvate thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.
    Type: Grant
    Filed: December 18, 2013
    Date of Patent: September 30, 2014
    Assignee: Merck Sharp & Dohme Corp.
    Inventors: Matthew P. Christopher, Francesc Xavier Fradera Llinas, Michelle Machacek, Michelle Martinez, Michael Hale Reutershan, Manami Shizuka, Binyuan Sun, Christopher Francis Thompson, B. Wesley Trotter, Matthew E. Voss, Michael D. Altman, Stephane L. Bogen, Ronald J. Doll
  • Publication number: 20140179680
    Abstract: The present invention provides substituted imidazopyridines as described herein or a pharmaceutically acceptable salt or solvate thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.
    Type: Application
    Filed: December 18, 2013
    Publication date: June 26, 2014
    Inventors: Matthew P. Christopher, Francesc Xavier Fradera Llinas, Michelle Machacek, Michelle Martinez, Michael Hale Reutershan, Manami Shizuka, Binyuan Sun, Christopher Francis Thompson, B. Wesley Trotter, Matthew E. Voss, Michael D. Altman, Stephane L. Bogen, Ronald J. Doll
  • Patent number: 6550631
    Abstract: A drinking vessel comprises a body part (10) to receive a drinks liquid, a lid (30) to seal the top of the body part, a liquid outlet passage (50, 52) extending down to a lower region of the interior space of the body part, and an air intake passage (54) also extending down to the lower region of the interior space of the body part. As the user draws liquid out of the vessel through the liquid outlet passage (50, 52), replacement air enters through the air intake passage (54) and then bubbles upwardly through the liquid within the vessel.
    Type: Grant
    Filed: November 29, 1999
    Date of Patent: April 22, 2003
    Assignee: Vogue International Limited
    Inventor: Christopher Mark Francis Thompson
  • Publication number: 20020053574
    Abstract: A drinking vessel comprises a body part (10) to receive a drinks liquid, a lid (30) to seal the top of the body part, a liquid outlet passage (50, 52) extending down to a lower region of the interior space of the body part, and an air intake passage (54) also extending down to the lower region of the interior space of the body part. As the user draws liquid out of the vessel through the liquid outlet passage (50, 52), replacement air enters through the air intake passage (54) and then bubbles upwardly through the liquid within the vessel.
    Type: Application
    Filed: November 29, 1999
    Publication date: May 9, 2002
    Inventor: CHRISTOPHER MARK FRANCIS THOMPSON
  • Patent number: 6299216
    Abstract: A joint comprising a main seal, a secondary seal and an external pressure test port providing access to a cavity between the main seal and the secondary seal wherein the integrity of the main seal can be tested in its in-service direction by applying pressure to the cavity via the pressure test port such that the cavity is pressurised and the main seal is tested. Following testing of the main seal, the secondary seal may become redundant during normal use of the joint. In some embodiments, however, the integrity of the main seal can be retested at any time due to the reusability of the secondary seal.
    Type: Grant
    Filed: February 26, 1999
    Date of Patent: October 9, 2001
    Assignee: Codelast Limited
    Inventor: David Francis Thompson
  • Patent number: 6154378
    Abstract: A polyphase AC-to-AC inverter (300) for driving a polyphase load (50), which may be an unbalanced load, includes a wye-connected AC voltage source (12) having a neutral terminal (312). The source (12) is coupled to a rectifying arrangement (16) for producing direct voltage across a direct-voltage bus (22). A capacitive bridge (24) on the DC bus (22) has a tap (26) connected to the neutral (312) of the source. The capacitive bridge is isolated from the AC source harmonics by a zero sequence inductor (20). The DC bus voltage at the capacitive bridge feeds a polyphase switching bridge (40). The average voltage at the output of the switching bridge is recovered by a low-pass filter (30) connected to the load. The unbalanced load current is conducted through an inductor to the capacitive bridge tap and the source neutral, with the inductor impedance isolating the load neutral from the DC bus. The switching bridge control can introduce triplen harmonics in the output to increase line-to-line output voltage.
    Type: Grant
    Filed: March 23, 1999
    Date of Patent: November 28, 2000
    Assignee: Lockheed Martin Corporation
    Inventors: William Anders Peterson, Michael Francis Thompson
  • Patent number: 5697630
    Abstract: There is provided hitching apparatus including a mounting means (10) including a base plate portion (11) supporting integrally formed struts (12) to which is fabricated an upper mounting socket (13). The base plate portion (11) is secured to the goose-neck of a vehicle by means of the threaded stud and nut of a conventional tow ball. The mounting socket (13) is adapted to receive the tongue portion (17) of a guide assembly including a pair of guide plates (21) which in use diverge from their mounting portion (20) to extend rearward and outward of the tow-ball. Reversing the vehicle to the hitch of the trailer with the hitching assembly installed results in either the hitch directly contacting the mounting portion (20) or engagement of the hitching portion with either of the guide plates (21) whereupon the hitching portion is guided to the mounting portion (20).
    Type: Grant
    Filed: November 17, 1995
    Date of Patent: December 16, 1997
    Assignee: Austvent Pty. Ltd.
    Inventors: Colin Gregory Thompson, Roland Francis Thompson
  • Patent number: 5684867
    Abstract: A method and apparatus for serving operator assistance calls from a remote operator assistance system but using the data base of the normal serving operator assistance system to verify the capability of the caller to place the desired call. The call is routed to the remote system where, for example, a specialized operator team, such as a Spanish speaking team, serves calls from an entire region or nation. The remote system accesses the data base of the normal serving system to obtain the data, describing the attributes of the caller, necessary to minimize the number of calls that are fraudulently completed.
    Type: Grant
    Filed: April 12, 1995
    Date of Patent: November 4, 1997
    Assignee: Lucent Technologies Inc.
    Inventors: John P. Gesslein, Jr., Robert Michael Jelinski, David Caswell McChristian, William Francis Thompson